These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16878620)

  • 1. Lipids: new guidelines, intensive treatment, and future directions.
    Jones PH
    Tex Heart Inst J; 2006; 33(2):180-3. PubMed ID: 16878620
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin effectively reduced all triglyceride-rich liporoteins (VLDL and LDL) in type 2 diabetes using VAP analysis.
    Cardiovasc J S Afr; 2006; 17(4):216. PubMed ID: 17001431
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of therapeutic lipid target achievements among high-risk patients in Oman.
    Al-Waili K; Al-Zakwani I; Al-Dughaishi T; Baneerje Y; Al-Sabti H; Al-Hashmi K; Farhan H; Habsi KA; Al-Hinai AT; Al-Rasadi K
    Angiology; 2014 May; 65(5):430-5. PubMed ID: 23564019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids and Cerebrovascular Disease: Research and Practice.
    Yaghi S; Elkind MS
    Stroke; 2015 Nov; 46(11):3322-8. PubMed ID: 26451029
    [No Abstract]   [Full Text] [Related]  

  • 5. Spotlight on HDL biology: new insights in metabolism, function, and translation.
    Rader DJ
    Cardiovasc Res; 2014 Aug; 103(3):337-40. PubMed ID: 25028388
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.
    Kulkarni M; Reaven PD
    Curr Diab Rep; 2002 Jun; 2(3):269-73. PubMed ID: 12643184
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid disorders in type 2 diabetes.
    Laakso M
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():43-5. PubMed ID: 20629231
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM; Bazaldua OV; Loffredo A
    J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multimodal therapy of dyslipidemia].
    Stahn A; Hanefeld M
    Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].
    Wascher TC; Paulweber B; Toplak H; Saely CH; Drexel H; Föger B; Hoppichler F; Stulnig T; Stingl H; Clodi M;
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):136-138. PubMed ID: 30980157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid lowering therapy in the treatment and secondary prevention of ischemic heart disease].
    Zimin IuV
    Kardiologiia; 2003; 43(4):74-83. PubMed ID: 12968608
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporating the new lipid guidelines into practice.
    Spear S
    JAAPA; 2014 Jun; 27(6):11. PubMed ID: 24803202
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial commentary: The long and winding road to follow dyslipidemia guidelines.
    Bonaventura A
    Trends Cardiovasc Med; 2024 Aug; 34(6):379-380. PubMed ID: 37673292
    [No Abstract]   [Full Text] [Related]  

  • 17. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM; Gaziano TA
    JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract]   [Full Text] [Related]  

  • 18. [New European and American guidelines on the management of blood cholesterol : similarities and differences].
    Butty A; Rodondi N; Nanchen D
    Rev Med Suisse; 2020 Mar; 16(684):438-443. PubMed ID: 32134222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.
    Masana L; Cabré A; Heras M; Amigó N; Correig X; Martínez-Hervás S; Real JT; Ascaso JF; Quesada H; Julve J; Palomer X; Vázquez-Carrera M; Girona J; Plana N; Blanco-Vaca F
    Atherosclerosis; 2015 Feb; 238(2):213-9. PubMed ID: 25528430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.